Efficacies and risks of aspirin in the treatment of the Kawasaki disease
Kusakawa, S.; Tatara, K.
Progress in Clinical and Biological Research 250: 401-413
1987
ISSN/ISBN: 0361-7742 PMID: 3423052 Document Number: 301855
Document emailed within 1 workday
Related Documents
De Caterina, R. 2003: Low-dose aspirin in the primary prevention of cardiovascular disease: how to balance the benefits and the risks Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4(4): 228-231Pignone, M.; Mulrow, C. 2002: Antiplatelet therapy and atherosclerotic events. Risks and patients' values need to be included in decision about aspirin for prevention of coronary heart disease Bmj 324(7342): 917
Lebranchu, Y. 1989: Kawasaki disease. Treatment with intravenous gammaglobulins Presse Medicale 18(23): 1147-1150
Singh, S.; Kumar, L. 1996: Kawasaki disease--treatment with intravenous immunoglobulin during the acute stage Indian Pediatrics 33(8): 689-692
Sangtawesin, C.; Kirawitaya, T.; Layangkool, T.; Nawasiri, W.; Vimolsarawong, N. 2003: Treatment of Kawasaki disease using locally product intravenous immunoglobulin Journal of the Medical Association of Thailand 86(Suppl 3): S656-S660
Yoshikane, Y.; Hirose, S. 2016: IVIG-steroids combination therapy for initial treatment of Kawasaki disease Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 6): 522-526
Selak, V.; Jackson, R.; Poppe, K.; Kerr, A.; Wells, S. 2018: Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease? New Zealand Medical Journal 131(1484): 19-25
Arj-ong, S.; Chotivitayatarakorn, P.; Lertsapcharoen, P.; Khongphatthanayothin, A.; Thisyakorn, C. 2003: A cost-benefit analysis of intravenous immunoglobulin treatment in children with Kawasaki disease Journal of the Medical Association of Thailand 86(Suppl): S179-S188
Atik, E.; Foronda, A.; Bustamante, L.N.P. 2003: Kawasaki disease. Involution of giant coronary aneurysms after prolonged anti-inflammatory treatment Arquivos Brasileiros de Cardiologia 81(3): 265-272
Yamamoto, N.; Morikawa, T.; Okubo, T.; Nakada, S.; Osawa, M.; Suzuki, A. 1980: Surgical treatment of coronary aneurysm after Kawasaki's disease (mucocutaneous lymphnode syndrome, MCLS) Kyobu Geka. Japanese Journal of Thoracic Surgery 33(8): 598-602
Sugimura, T.; Yokoi, H.; Sato, N.; Akagi, T.; Kimura, T.; Iemura, M.; Nobuyoshi, M.; Kato, H. 1997: Interventional treatment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease Circulation 96(11): 3928-3933
1980: Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group Circulation 62(3): 449-461
Yokoyama, T.; Yamashita, K.; Yamasaki, F.; Ueta, T.; Manabe, M.; Nishiyama, T. 2003: Aspirin reversal--an incremental administration of aspirin shortens the bleeding time prolonged by low-dose aspirin Masui. Japanese Journal of Anesthesiology 52(4): 399-401
Szmidt, M.; Grzelewska-Rzymowska, I.; Rozniecki, J.; Grzegorczyk, J. 1991: Neutrophil chemotactic activity after administration of aspirin during aspirin tolerance in patients with asthma and aspirin hypersensitivity Pneumonologia i Alergologia Polska 59(1-2): 16-21
Mutter, J.; Grandy, R.; Hulkower, S.; Stigleman, S. 2018: Clinical Inquiries: What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events? Journal of Family Practice 67(4): 247-248
Katz, L.B.; Shriver, D.A. 1989: Rioprostil heals pre-existing aspirin-induced gastric lesions in dogs during daily aspirin administration without altering the anti-inflammatory or analgesic efficacy of aspirin Journal of Pharmacology and Experimental Therapeutics 251(2): 774-781
Born, G.V. 1990: Anti-thrombotic drugs in the treatment of coronary heart disease: the present situation with aspirin Zeitschrift für Kardiologie 79(Suppl 3): 147-150
Kahn, G. 1978: Mucocutaneous lymph node syndrome (Kawasaki's disease). a new disease remaking its debut Archives of Dermatology 114(6): 948-950
Tu, J.; Ji, J.; Wu, F.; Zhang, D.; Ying, X.; Zhao, Z. 2014: Efficacies of ¹³¹I-chTNT plus radiofrequency ablation for the treatment of advanced hepatocellular carcinoma Zhonghua Yi Xue Za Zhi 94(45): 3586-3588
Livi, U.; Rizzoli, G.; Corbara, F.; Chioin, R.; Aru, G.; Milano, A.; Bortolotti, U.; Mazzucco, A.; Valfré, C.; Gallucci, V. 1982: Surgical treatment of patients with trivalvular disease: results and evaluation of perioperative risks Cardiologia 27(3): 295-301